Clinical Trials Browser

Phase 1 × Completed × Soft Tissue Neoplasms × Clear all

NCT03159585 2020-01-22

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Soft Tissue Neoplasms, Stomach Neoplasms, Thyroid Neoplasms